Report #2861494

Overview

Sex

Female

Age

76 yrs

State

—

Recovered

Not recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (4)

Symptom narrative

profuse sweating; mobility issues; muscle aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (profuse sweating), MOVEMENT DISORDER (mobility issues), MYALGIA (muscle aches) and NAUSEA (nausea) in a 76-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (profuse sweating), MOVEMENT DISORDER (mobility issues), MYALGIA (muscle aches) and NAUSEA (nausea). At the time of the report, HYPERHIDROSIS (profuse sweating), MOVEMENT DISORDER (mobility issues), MYALGIA (muscle aches) and NAUSEA (nausea) was resolving. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medication was reported. The patient had severe side effects such as profuse sweating, muscle aches, nausea, and mobility issues after receiving the COVID-19 vaccine and was inquiring about the duration of these symptoms. It was unknown if the patient experienced any additional symptoms or events. No treatment medication was reported. Reporter causality was not reported.